Skip to content

Released Aug 14, 2014, after the close

10-Q filed Aug 14, 2014, 45 days after period end · 0001144204-14-050130

Q2 2014 · 10-Q
Revenue—
Net Income-$2.47MN/M vs Q2 2013N/M vs Q1 2014
EPS Diluted-$0.52N/M vs Q2 2013N/M vs Q1 2014
Operating Income-$2,506,144N/M
Operating Cash Flowderived-$2,320,394—
Free Cash Flowderived-$2,320,394—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2014Q2 2013Q2 2012Q2 2011
Net Income-$2.47M-$4.75M-$7.47M-$6.96M
EPS Diluted-$0.52-$1.20-$0.59-$0.97

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR